Therapeutic approaches for the prevention of secondary brain injury

European Journal of Anaesthesiology

Volumn 13, Issue 3, 1996, Pages 291-309

  McIntosh, T K ^a   Smith, D H ^a   Garde, E ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Brain injury; Calcium; Excitatory amino acids; Free radicals; Pharmacology; Treatment

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; ANTIINFLAMMATORY AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALPASTATIN; CATECHOLAMINE; EXCITATORY AMINO ACID RECEPTOR; FREE RADICAL; GLYCINE; GROWTH FACTOR; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; OPIATE ANTAGONIST;

BRAIN INJURY; CATECHOLAMINE RELEASE; CHOLINERGIC TRANSMISSION; CRYOANESTHESIA; ENCEPHALITIS; HUMAN; LIPID PEROXIDATION; NEUROCHEMISTRY; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW;

EID: 0030014359     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199605000-00007     Document Type: Review

References (260)

1. Cooper PR. Delayed Brain Injury: Secondary Insults. National Institute of Neurological and Communicative Disorders and Stroke, Maryland: National Institutes of Health, 1985: 217-228.
2. Siesjö BK, Weiloch T. Brain injury: neurochemical aspects. CNS Trauma Status Report 1985: 513-532.
3. Siejö BK. Brain Energy Metabolism, New York: John Wiley, 1978.
4. Shapira Y, Yadid G, Cotev S, Shohami E. Accumulation of calcium in the brain following head trauma. Neurol Res 1989; 11: 169-171.
5. Thomas MJ, Breault D, Nolan B, Smith DH, McIntosh TK. Effects of experimental brain injury on regional cation homeostasis. Neurosci Abstr 1990; 16(1): (abstract) 777.
6. 2+ levels following cortical compression contusion trauma in rats. J Cereb Blood Flow Metab 1993; 13: 183-192.
7. 45Ca autoradiographic study. Brain Res 1993; 624: 94-102.
8. Dorsch NWC, Branston NM, Harris RJ, Bentivoglio P, Symon L. An experimental study of the effect of nimodipine in primate subarachnoid haemorrhage. Acta Neurochir 1987; 99: 65-75.
9. Allen G, Ahn H, Preziosi T et al. Cerebral vasospasm - a control trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983; 308: 619-624.
10. Baethmann A, Jansen M. Possible role of calcium entry blockers in brain protection. Eur Neurol 1986; 25: 102-114.
11. Ohman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 1988; 69: 683-686.
12. Philippon J, Grob R, Dagreou F, Guggliari M, Rivierez M, Viars P. Prevention of vasospasm in subarachnoid hemorrhage. A control study with nimodipine. Acta Neurochir 1986; 82: 110-114.
13. Pikard JD, Murray GD, Illingworth R et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 1989; 298: 636-642.
14. Robinson MJ, Teasdale G. Calcium antagonists in the management of subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1990; 2: 205-226.
15. LeVere TE, BruglerT, Sandin M, Gray-Silva S. Recovery of function after brain damage: facilitation by the calcium entry blocker nimodipine. Behav Neurosci 1989; 103: 561-565.
16. Yuan X-Q, Smith TL, Prough D et al. Long-term effects of nimodipine on pial microvasculature and systemic circulation in conscious rats. Am J Physiol 1990; 258: H1395-H1401.
17. Gentile N, Smith DG, Burhans C, McIntosh TK. Cognitive and neurologic functions and hippocampal neuronal loss after nimodipine in fluid percussion brain injury. J Neurotrauma 1993; 10: (abstract) S193.
18. Okiyama K, Smith DH, Thomas MJ, McIntosh TK. Effects of calcium channel blocker (S)-emopamil on experimental brain injury. J Cereb Blood Flow Metab 1991; 11(2) (Suppl.): (abstract) S708.
19. Okiyama K, Smith DH, Thomas MJ, McIntosh TK. Evaluation of a novel calcium channel blocker (S)-emopamil on regional cerebral edema and neurobehavioral function after experimental brain injury. J Neurosurg 1992; 77: 607-615.
20. Okiyama K, Rosenkrantz TS, Smith DH, Gennarelli TA, McIntosh TK. (S)-Emopamil attenuates regional cerebral blood flow reduction following experimental brain injury. J Neurotrauma 1994; 11: 83-95.
21. Bodie H, Fu K, Sanit A, Hovda D. A selective N-channel calcium blocker attenuates the injury-induced accumulation of calcium following experimental traumatic brain injury. J Neurotrauma 1993; 10: S161.
22. Kostron H, Twerdy K, Stampfl G, Mohsenipour I, Fischer J, Grunert V. Treatment of the traumatic cerebral vasospasm with the calcium channel blocker nimodipine. Neurol Res 1984; 6: 29-32.
23. Kostron H, Rumpl E, Stampfl G, Russegger L, Grunert V. Treatment of cerebrovasospasm following severe head injury with the calcium channel influx blocker nimodipine. Acta Neurochir (Wein) 1985; 28: 103-109.
24. Compton JS, Lee T, Jones NC, Waddell G, Teddy PJ. A double-blind placebo controlled trial of the calcium entry blocking drug nicardipine in the treatment of vasospasm following severe head injury. Br J Neurosurg 1990; 4: 9-16.
25. Teasdale G. A randomized trial of nimodipine in severe head injury: HIT 1. J Neurotrauma 1991; 37: S545-S550.
26. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 1994; 8: 814-822.
27. Siman R, Baudry M, Lynch G. Brain fodrin: substitute for calpain I, an endogenous calcium-activated protease. Proc Natl Acad Sci 1984; 81: 3572-3576.
28. Billger M, Walling M, Karlson JO. Proteolysis of tublin and microtubule-associated proteins 1 and 2 by calpain I and II. Cell Calcium 1989; 9: 33-44.
29. Johnson GVW, Litersky JM, Jope RS. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J Neurochem 1991; 56(5): 1630-1638.
30. 2-, and its effect on the neurofilament triplet. J Neurosci Res 1985; 13: 391-403.
31. Schlaepfer WE, Zimmerman U-JP. The degradation of neurofilaments by calpains. In: Intracellutar Calcium-Dependent Proteolysis. CRC Press, 1990: 241-249.
32. Takahashi K. Calpain substrate specificity. In: Mellgren RL, Murachi T, eds. Intracellular Calcium-Dependent Proteolyis. New York: CRC Press, 1990: 55-74.
33. Siman R, Noszek JC, Kegerise C. Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 1989; 9: 1579-1590.
34. Lynch G, Larson J, Baudry M. Proteases, neuronal stability, and brain aging: a hypothesis. In: Crook T, Bartus R, Ferris S, Gershon S, eds. Treatment Development Strategies for Alzheimer's Disease. St. Louis, MO: Mark Pawley Assoc., 1986: 119-149.
35. Roberts-Lewis JM, Savage MJ, Marcy VR, Pinsker LR, Siman R. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 1994; 14(6): 3834-3944.
36. Bartus RT, Elliot PJ, Hayward NJ et al. Calpain as a novel target for treating acute neurodegenerative disorders. Neurol Res 1995; 17: 249-258.
37. Wang KKW, Yuen P-W. Calpain inhibition: an overview of its therapeutic potential. TIPS 1995; 15: 412-419.
38. Bartus RT, Baker KL, Heiser AD et al. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J Cereb Blood Flow Metab 1994; 14: 537-544.
39. Bartus RT, Hayward NJ, Elliott PJ et al. Calpain inhibitor AK295 protects neurons from focal brain ischemia: effects of postocclusion intraarterial administration. Stroke 1994; 25: 2265-2270.
40. Hong S-C, Goto Y, Lanzino G, Soleau S, Kassell NF, Lee KS. Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 1994; 25(3): 663-669.
41. Rami A, Krieglstein J. Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 1993; 609: 67-70.
42. Lee KS, Frank S, Vanderklish P, Arai A, Lynch G. Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci 1991; 88: 7233-7237.
43. Inuzuka T, Tamura A, Sato S, Kirino T, Toyoshima I, Miyatake T. Suppressive effect of E-64c on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats. Brain Res 1990; 526: 177-179.
44. Saatman KE, Murai H, Bartus RT, Hayward NJ, Perri BR, McIntosh TK. The calpain inhibitor AK295 improves outcome following experimental brain injury. Proc Natl Acad Sci 1995; 00: 000-000. (In press.)
45. Jennett B, Teasdale G. Management of Head Injuries. Contemporary Neurology Series. Volume 20, Philadelphia: Davis, 1981.
46. Clifton G, McCormick WF, Grossman R. Neuropathology of early and late deaths after head injury. Neurosurgery 1981; 8: 309-314.
47. Hamill RW, Woolf PD, McDonald J, Lee LA, Kelley M. Catecholamines predict outcome in traumatic brain injury. Ann Neurol 1987; 212: 43-443.
48. Woolf PD, Hamill RW, Lee LA, Cox C, McDonald J. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg 1987; 66: 875-882.
49. Prasad MR, Tzigaret C, Smith DH, Soares HD, McIntosh TK. Decreased alpha-adrenergic receptors after experimental brain injury. J Neurotrauma 1992; 9: 269-279.
50. Rosner MJ. Systematic response to experimental brain injury. In: Becker DP, Povlishock J, eds. Central Nervous System Trauma Status Report, Bethesda, Maryland: National Institutes of Health, 1985: 405-416.
51. McIntosh TK, Yu T, Gennarelli TA. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem 1994; 63: 1426-1433.
52. Prasad MR, Ramaiah C, McIntosh TK, Dempsey RJ, Hipkens S, Yurek D. Regional levels of lactate and norepinephrine after experimental brain injury. J Neurochem 1994; 63: 1086-1094.
53. Pappius HM, Dadoun R. Effects of injury on the indoleamines in cerebral cortex. J Neurochem 1987; 49: 321-325.
54. Pappius HM. Local cerebral glucose utilization in thermally traumatized rat brain. Am J Neurol 1981; 9: 484-491.
55. Pappius HM, Dadoun R, McHugh M. The effect of p-chlorophenylalanine on cerebral metabolism and biogenic amine content of traumatized brain. J Cereb Blood Flow Metab 1988; 8: 324-334.
56. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury. I. Methodology and local effects of contusions in the rat Brain Res 1981; 211: 67-77.
57. Dail WG, Feeney DM, Murray HM, Linn RT, Boyeson MG. Responses to cortical injury. H. Widespread depression of the activity of an enzyme in cortex remote from focal injury. Brain Res 1981; 211: 79-89.
58. Weaver MS, Chen MJ, Westerberg VS, Feeney DM. Locus coeruleus lesions facilitate recovery of locomotor function after sensorimotor cortex contusion in rat. Neurosci Abstr 1988; 14: (abstract) 1451.
59. Romhanyi R, Tandian D, Hovda DA et al. Catecholaminergic stimulation enhances recovery of function following concussive brain injury. J Neurotrauma 1990; 9: 164.
60. Tandian D, Romhanyi R, Hovda DA et al. Amphetamine enhances both behavior and metabolic recovery following fluid percussion brain injury. J Neurotrauma 1990; 9: 174.
61. Sutton RL, Feeney DM. α-noradrenergic agonists and antagonists affect recovery and maintenance of beamwalking ability after sensorimotor cortex ablation in the rat. Restorat Neurol Neurosci 1992; 4: 1-11.
62. Bornstein M. Presence and action of acetylcholine in experimental brain trauma. J Neurophysiol 1946; 9: 349-366.
63. Ruge D. The use of cholinergic blocking agents in the treatment of craniocerebral injuries. J Neurosurg 1945; 11: 77-83.
64. Tower D, McEachern D. Acetylcholine and neuronal activity in craniocerebral trauma. J Clin Invest 1948; 27: 558-559.
65. West M, Labella FS, Havlicet V, Parkinson D. Cerebral concussion in rats rapidly induces hypothalmic specific effects on opiate and cholinergic receptors. Brain Res 1981; 225: 271-277.
66. Hayes RL, Stonnington H, Lyeth BG, Dixon E, Yamamoto T. Metabolic and neurophysiologic sequelae of brain injury: a cholinergic hypothesis. J Neurotrauma 1986; 3: 163-173.
67. Hayes RL, Chapouris RG, Lyeth BG et al, Pretreatment with phencyclidine (PCP) attenuates long-term behavioral deficits following concussive brain injury in the rat. Soc Neurosci Abstr 1987; 13: 1254.
68. Katayama Y, DeWitts DS, Becker DP, Hayes RL. Behavioral evidence for a cholinoceptive pontine inhibitory area: descending control of spinal motor output and sensory input. Brain Res 1984; 296: 241-262.
69. Katayama Y, Becker DP, Hayes RL. Depression of afferent-induced primary afferent depolarization at the lumbar cord following concussive head injury. Brain Res 1985; 335: 392-395.
70. Katayama Y, Reuther S, Dixon E, Becker DP, Hayes RL. Dissociation of endogenous components of auditory evoked potentials following carbachol microinjections into the cholinoceptive pontine inhibitory area. Brain Res 1985; 334: 366-371.
71. Hayes RL, Jenkins LW, Lyeth BG et al. Pretreatment with phencyclidine, an N-methyl-d-aspartate antagonist, attenuates long-term behavioral deficits in the rat produced by traumatic brain injury. J Neurotrauma 1988; 5: 259-274.
72. Lyeth BG, Hayes RL. Cholinergic and opioid mediation of traumatic brain injury. J Neurotrauma 1992; 9: S463-S474.
73. Lyeth BG, Jenkins LW, Clifton G, Hayes RL. A possible role of scopolamine in treating human head injury. In: Miner ME, Gardner KA, eds. Neurotrauma: Monitoring and Treatment. Boston: Butterworth, 1990.
74. Lyeth BG, Dixon CE, Hamm R et al. Effects of anticholinergic treatment on transient behavioral suppression and physiological responses following concussive brain injury to the rat. Brain Res 1988; 488: 88-97.
75. Lyeth BG, Dixon CE, Jenkins LW et al. Effects of scopolamine treatment on long-term behavioral deficits following concussive brain injury to the rat. Brain Res 1988; 452: 39-97.
76. Lyeth BG, Ray M, Hamm R et al. Postinjury scopolamine administration in experimental traumatic brain injury. Brain Res 1992; 569: 281-286.
77. Saija A, Hayes RL, Lyeth BG, Dixon E, Yamamoto T, Robinson S. The effect of consecutive head injury on central Cholinergic neurons. Brain Res 1988; 452: 303-311.
78. McIntosh TK, Head VA, Faden AI. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res 1987; 425: 225-233.
79. McIntosh TK, Hayes RL, DeWitts DS, Agura V, Faden AI. Endogenous opioids may mediate secondary damage after experimental brain injury. Am J Physiol 1987; 253: E565-E574.
80. McIntosh TK, Faden AI. Opiate antagonists in CNS injury. In: Stein DG, ed. Pharmacologic Approaches to Recovery from Brain Injuries. New York: Plenum Press, 1988: 89-99.
81. Hayes RL, Galinet BJ, Kulkarne P, Becker DP. Effects of naloxone on systemic and cerebral responses to experimental concussive brain injury in cats. J Neurosurg 1983; 58: 720-728.
82. McIntosh TK, Fernyak S, Faden AI. The effects of naloxone hydrochloride treatment after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab (Suppl 2) 1991; S734.
83. Robinson SE, Lyeth BG, Jenkins LW et al. The effect of naloxone pretreatment on behavioral responses to concussive brain injury in the rat. Neurosci Abstr 1987; 2: 1254.
84. 2+, bioenergetic state and neurological outcome following traumatic brain injury in rats. J Neurosci 1990; 10: 3524-3530.
85. Vink R, Portoghese PS, Faden AI. k-opioid antagonist improves cellular bioenergetics and recovery after traumatic brain injury. Am J Physiol 1991; 261: R1527-R1532.
86. Holaday JW, Tseng L-F, Loh HH, Li H. Thyrotropin releasing hormone antagonizes b-endorphin hypothermia and catalepsy. Life Set 1978; 22: 1537-1543.
87. Manaka S, Sano K. Thyrotropin-releasing hormone tartrate (TRH-t) shortens concussion effects following head impact in mice. Neurosci Lett 1978; 8: 255-258.
88. Fukuda N, Yuoshiaki S, Nagawa Y. Behavioral and EEG alterations with brain stem compression and effect of thryotropin-releasing hormone (TRH) in chronic cats. Folia Pharmacol Japonica 1979; 75: 321-331.
89. McIntosh TK, Vink R, Faden AI. An analogue of thyrotropin-releasing hormone improves outcome after brain injury; 31P-NMR studies. Am J Physiol 1988; 257: R785-R792.
90. McIntosh TK, Vink R, Faden AI. Beneficial effect of the TRH analog CG-3703 on brain bioenergetics and survival following traumatic brain injury in rats. In: Lever A, ed. Perspectives in Shock Research. New York: R. Liss, 1988: 415-420.
91. Vink R, McIntosh TK, Faden AI. Treatment with the thyrotropin releasing hormone analog CG3703 restores magnesium homeostasis following traumatic brain injury in rats. Brain Res 1988; 460: 184-188.
92. Faden AI. TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies. Brain Res 1989; 486: 228-235.
93. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989; 244: 789-800.
94. Kawamata T, Katayama Y, Hovda DA, Yoshino Y, Becker DP. Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury. J Cereb Blood Flow Metab 1992; 12: 12-24.
95. 3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain. Br J Pharmacol 1988; 95: 932-938.
96. Schoepp DD, Ornstein PL, Leander JD et al. Pharmacol characterization of LY233053: a structurally novel tetrazole-substituted competitive N-methyl-D-aspartic acid antagonist with a short duration of action. J Pharmacol Exp Ther 1990; 255: 1301-1308.
97. Glatt BS, Raghupathi R, Gennarelli TA, McIntosh TK. Effect of simultaneous blockade of opiate and glutamate receptors on neurobehavioral outcome following experimental brain injury. J Neurotrauma 1995; 12: (abstract) 118.
98. Smith DH, Thomas MJ, Soares HD, McIntosh TK. Differential effects of competitive and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists in experimental brain injury. FASEB J 1990; 4(3): (abstract) 773.
99. Panter SS, Faden AI. Pretreatment with the NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci Lett 1992; 136: 165-168.
100. Wong EHF, Knight AR, Woodruff GN. <13H>MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 1988; 50: 274-281.
101. Feigenbaum JJ, Bergmann F, Richmond SA et al. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci 1989; 86: 9584-9687.
102. Shapira Y, Yadid G, Cotev S, Niska A, Shohami E. Protective effect of MK-801 in experimental brain injury. J Neurotrauma 1990; 7: 131-139.
103. Shohami E, Novikov M, Mechoulam R. A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J Neurotrauma 1993; 10: 109-119.
104. Smith DH, Okiyama K, Gennarelli TA, McIntosh TK. Magnesium and ketamine attenuate cognitive dysfunction following experimental brain injury. Neurosci Lett 1993; 157: 211-214.
105. Shapira Y, Lam AM, Artu AA, Eng C, Soltow L. Ketamine alters calcium and magnesium in brain tissue following experimental head trauma in rats. J Cereb Blood Flow Metab 1993; 13: 962-968.
106. Olney JW, Labruyere J, Price M. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-1362.
107. Sharp F, Jasper P, Hall J, Noble L, Sagar SM. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol 1991; 30: 801-809.
108. 2+ is associated with irreversible tissue injury following brain trauma. J Biol Chem 1988; 263: 757-761.
109. McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats. 31P Magnetic resonance spectroscopy and behavioral studies. J Neurotrauma 1988; 5: 17-31.
110. McIntosh TK, Vink R, Yamakami I, Faden AI. Magnesium protects against neurological deficit after brain injury. Brain Res 1989; 482: 252-260.
111. Okiyama K, Smith DH, Gennarelli TA, Simon RP, Leach M, McIntosh TK. The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat. J Neurochem 1995; 64(2): 802-809.
112. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529-531.
113. Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 1988; 241: 835-837.
114. Smith DH, Okiyama K, Thomas MJ, Mcintosh TK. Effects of the excitatory amino acid receptor antagonists kynurenate and indole-2-carboxylicacid on behavioral and neurochemical outcome following experimental brain injury. J Neurosci 1993; 13: 5383-5392.
115. Hicks RR, Smith DH, Mcintosh TK. Kynurenate is neuroprotective following experimental brain injury in the rat. Brain Res 1994; 655: 91-96.
116. 3H]MK-801 binding to the N-methyl-D-aspartate receptor-ion channel complex by L-glutamate, glycine and polyamines. J Neurochem 1988; 51: 830-836.
117. Carter C, Rivy JP, Scatton B. Ifenprodil and SL 82.0715 are antagonists at the polymine site of the N-methyl-D-aspartate (NMDA) receptor. Eur J Pharmacol 1989; 164: 611-612.
118. Toulmond S, Serrano A, Benavides J, Scatton B. Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window. Brain Res 1993; 620: 32-41.
119. Dovevan SD, Rogawski MA. GYKI 52466, a 2,3-benzodiazepine, is a highly selective noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 1993; 10: 51-59.
120. Hylton C, Perri BR, Voddi MD et al. Non-NMDA antagonist GYKI 52466 enhances spatial memory after experimental brain injury. J Neurotrauma 1995; 12: (abstract) 124.
121. Miller AA, Sawyer DA, Roth B et al. Lamotrigine. In: Meldrum BS, Porter RJ, eds. New Anticonvulsant Drugs. London: John Libbey, 1986: 165-177.
122. Meldrum BS, Swan JH, Leach MJ et al. Reduction of glutamate release and protection against ischemic brain damage by BW1003C87. Brain Res 1992; 593: 1-6.
123. Voddi MD, Perri BR, Perlman KG, Smith DH, Leach M, Mcintosh TK. The pre-synaptic glutamate release inhibitor BW619C89 attenuates memory dysfunction following experimental brain injury. J Neurotrauma 1995; 12: (abstract) 146.
124. Mcintosh TK, Voddi M, Smith DH, Stutzmann J-M. Riluzole, a compound which interferes with glutamate neurotransmission, improves cognitive deficits following experimental brain injury in rats. J Neurotrauma 1995; 12: (abstract) 379.
125. Hall ED, Wolf DL. A pharmacological analysis of the pathophysiological mechanisms of post-traumatic spinal cord ischemia. J Neurosurg 1986; 64: 951-961.
126. Kontos HA, Wei E, Ellis EF, Povlishock JT, Dietrich W. Prostaglandins in physiological and in certain pathological responses of the cerebral circulation. Fed Proc 1985; 40: 2326-2330.
127. Kontos H, Wei E, Ellis EF et al. Appearance of Superoxide radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ Res 1985; 57: 142-151.
128. Kontos H, Povlishock JT. Oxygen radicals in brain injury. Cent Nerv Sys Trauma 1986; 3: 257-263.
129. Kontos HA. Oxygen radicals in central nervous system damage. Chem Biol Interact 1989; 72: 229-255.
130. Siesjö BK, Wieloch T. Brain injury: neurochemical aspects. In: Becker DP, Povlishock J, eds. Central Nervous System Trauma Status Report. Bethesda, Maryland: National Institutes of Health, 1985: 513-532.
131. Young W. The role of calcium in spinal cord injury. Cent Nerv Sys Trauma 1985; 2(2): 109-114.
132. Young W. The post-injury response in trauma and ischemia. Secondary injury or provocative mechanisms? Cent Nerv Sys Trauma 1987; 4: 27-51.
133. Chan P, Fishman R. Transient formation of Superoxide radicals in polyunsaturated fatty acid induced brain swelling. J Neurochem 1980; 35: 1004-1007.
134. Chan P, Fishman R. Oxygen-free radicals: potential edema mediators in brain injury, In: Brain Edema. Berlin: Springer Verlag, 1985: 317-323.
135. Demopoulos HB, Flamm ES, Seligman ML, Peitronigro DD. Oxygen free radicals in central nervous system ischemia and trauma. In: Autor AP, ed., London: Academic Press, 1982: 127-155.
136. Flamm ES, Demopoulos HB, Seligman ML. Free radicals in cerebral ischemia. Stroke 1978; 9: 445-447.
137. Ginsberg M, Watson BD, Busto R. Peroxidative damage to cell membranes following cerebral ischemia. A cause of ischemic brain injury? Neurochem Pathol 1988; 9: 171-193.
138. Kontos HA. Oxygen radicals in cerebral vascular injury. Circ Res 1985; 57: 508-516.
139. Lundgren J, Zhang H, Agardh CD et al. Acidosis-induced ischemic brain damage: are free radicals involved? J Cereb Blood Flow Metab 1991; 11: 587-596.
140. Traystman RJ, Kirsch JR, Koehler RC. Oxygen radical mechanisms of brain injury following ischemia and reperfusion. J Appl Physiol 1991; 71: 1185-1195.
141. Yoshida S, Busto R, Ginsberg M. Compression induced brain edema: modification by prior depletion and supplementation of vitamin E. J Cereb Blood Flow Metab 1983; 33: 166-172.
142. Anderson DK, Saunders R, Demediuk P, Means E. Lipid hydrolysis and peroxidation in injured spinal cord: Partial protection with vitamin E or selenium. J Neurotrauma 1986; 2: 257-268.
143. Anderson D, Braughler M, Hall E, Waters T, McCall J, Means E. Effects of treatment with U74006F on neurological outcome following experimental spinal cord injury. J Neurosurg 1988; 69: 562-567.
144. Hsu C, Halushka P, Hogan E, Banik N, Lee W, Perot P. Alterations of thromboxane and prostocyclin levels in perimental spinal cord injury. Neurology 1985; 35: 1003-1009.
145. Hsu C, Halushka P, Hogan E, Cox R. Increased thromboxane level in experimental spinal cord injury. J Neurol Sci 1986; 74: 289-296.
146. Pielronigra DD, Hovsepian M, Demopoulos HB, Flamm ES. Loss of ascorbic acid from injured feline spinal cord. J Neurochem 1983; 41: 1072-1076.
147. Xu J, Beckman JS, Hogan EL, Hsu CY. Xanthine oxidase in experimental spinal cord injury. J Neurotrauma 1991; 8: 11-18.
148. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988; 19: 480-485.
149. Yamamoto M, Shina T, Vozumi T, Sogabe T, Yamada K, Kawasaki T. A possible role of lipid peroxidation in cellular damage caused by cerebral ischemia and the protective effect of α-tocopherol administration. Stroke 1983; 14: 977-982.
150. Yoshida S, Busto R, Watson BD. Postischemic cerebral lipid peroxidation in vitro: modification by dietary vitamin E. J Neurochem 1985; 44: 1593-1601.
151. Anderson D, Saunders R, Demediuk P et al. Lipid hydrolysis and peroxidation in injured spinal cord: partial protection with methyiprednisolone or vitamin E and selenium. J Neurotrauma 1985; 2: 257-267.
152. Saunders RD, Dugan L, Demediuk P, Means E, Horrocks L, Anderson DK. Effects of methyl prednisolone and the combination of a-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 1987; 49: 24-31.
153. Chan P, Longar S, Fishman R. Protective effects of liposome-entrapped Superoxide dismutase on post-traumatic brain edema. Ann Neurol 1987; 21: 540-547.
154. Sakaki S, Ohta S, Wakamura H, Takeda S. Free radical reaction and biological defense mechanism in the pathogenesis and prolonged vasospasm in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab 1988; 8: 1-8.
155. Clifton G, Lyeth BG, Jenkins LW, Taft WC, DeLorenzo RJ, Hayes RL. Effect of D1 α-tocopheryl succinate and polyethylene glycol on performance tests after fluid percussion brain injury. J Neurotrauma 1989; 6: 71-81.
156. Hall ED, Yonkers PA, Horan KL, Braughler JM. Correlation between attenuation of post-traumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F. Evidence for an in vivo antioxident mechanism. J Neurotrauma 1989; 6: 169-176.
157. Wei E, Kontos H, Dietrich W, Povlishock JT, Ellis EF. Inhibition by free radical scavengers and by cycooxygenase inhibitors of pial arteriolar abnormalities from concussive brain injury in cats. Circ Res 1981; 48: 95-103.
158. Stein DG, Halks-Miller M, Hoffman SW. Intracerebral administration of a-tocopherol-containing liposomes facilitates behavioral recovery in rats with bilateral lesions of the frontal cortex. J Neurotrauma 1991; 8: 281-292.
159. Panter SS, Braughler JM, Hall E. Dextran-coupled deferoxamine improves outcome in a murine mode of head injury. J Neurotrauma 1992; 9: 47-53.
160. Martz D, Beer D, Betz AL. Dimethyl thiourea reduces ischemic brain edema without affecting cerebral blood flow. J Cereb Blood Flow Metab 1990; 10: 352-357.
161. Lim KH, Connolly M, Rose D et al. Prevention of reperfusion injury of the ischemic spinal cord: use of recombinant Superoxide dismutase. Ann Thorac Surg 1986; 42: 282-286.
162. Forsman M, Fleischer JE, Milde J, Steen P, Michenfelder J. Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog. Acta Anaesthesiol Scand 1988; 32: 152-155.
163. Coles JC, Ahmed SN, Mehta ITU, Kaufman JC. Role of radical scavenger in protection of spinal cord during ischemia. Ann Thorac Surg 1986; 41: 555-556.
164. Joshita H, Asano T, Hananure T, Takakura K. Effect of indomethacin and a radical scavenger on cerebral blood flow and edema after cerebral artery occlusion in cats. Stroke 1989; 20: 788-794.
165. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene-glycol-conjugated Superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 1989; 256: H589-H592.
166. Matsumiya N, Kochler RC, Kirsch JR, Traystman RJ. Conjugated Superoxide dismutase reduces extent of caudate injury after transient focal ischemia in cats. Stroke 1991; 226: 1193-1200.
167. Chan P. Antioxidant-dependent amelioration of brain injury: role of CuZn-superoxide dismutase. J Neurotrauma 1992; 9: S417-S427.
168. Muizelaar JP, Marmarou A, Young HF et al. Improving the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol-conjugated superoxide dismutase: a phase II trial. J Neurosurg 1993; 78: 375-382.
169. Braughler JM, Hall E. High dose methylprednisolone and CNS injury. J Neurosurg 1988; 64: 985-986.
170. Braughler J, Pregenzer J, Chase R, Duncan L, Jacobsen E, McCall J. Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 1987; 262: 10434-10440.
171. Hall E, Braughler J. Role of lipid peroxidation in post-traumatic spinal cord degeneration - a review. J Neurotrauma 1986; 3: 281-294.
172. Braughler J, Hall E. Correlation of methylprednisolone pharmacokinetics in cat spinal cord with its effect on (Na + K + )ATPase, lipid peroxidation and motor neuron function. J Neurosurg 1981; 56: 838-844.
173. Braughler J, Duncan L, Chase R. Interactions of lipid peroxidation in calcium in the pathogenesis of neuronal injury. J Neurotrauma 1985; 2: 269-283.
174. Braughler J, Lainer M. The effects of large doses of methylprednisolone on neurologic recovery and survival in the Mongolian gerbil following three hours of unilateral carotid occlusion. J Neurotrauma 1986; 3: 153-161.
175. Hall E. High-dose glucocorticoid treatment improves neurological recovery in head injured mice. J Neurosurg 1985; 62: 882-887.
176. Hall ED, McCall JM, Chase RL, Yonkers PA, Braughler JM. A non-glucocorticoid steroid analog of methyl-prednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage. J Pharmacol Exp Ther 1987; 242: 137-142.
177. Braakman R, Schouten HJ, Dishoeck MB, Minderhoud JM. Megadose steroids in severe head injury. J Neurosurg 1983; 58: 326-330.
178. Cooper PR, Moody S, Clark WK et al. Dexamethasone and severe head injury. J Neurosurg 1979; 51: 307-316.
179. Gudeman SK, Miller JD, Becker DP. Failure of highdose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg 1979; 51: 301-306.
180. Gianotta SL, Weiss MH, Apuzzo ML, Martin E. High dose glucocorticoids in the management of severe head injury. Neurosurgery 1984; 15: 497-501.
181. Braken MB, Shepard MJ, Collins WF et al. A randomized controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 1990; 322(20): 1405-1411.
182. Bracken MB, Shepard MJ, Collins WF et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1 year follow-up data. J Neurosurg 1992; 76: 23-31.
183. Braughler J, Chase R, Neff G, Pregenzer J, Jacobsen E, McCall J. A new 21-aminosteroid antioxidant lacking glucocorticoid activity stimulates adrenocorticotropin secretion and blocks arachidonic acid release from mouse pituitary tumor. J Pharmacol Exp Ther 1988; 244; 423-427.
184. Braughler J, Pregenzer J. The 21-aminosteroid inhibitors of lipid peroxidation: reactions with lipid peroxy and phenoxy radicals. Free Rad Biol Med 1989; 7: 125-130.
185. Hall E, Paraza KE. Effects of novel 2T-aminosteroid antioxidants on postischemic neuronal degeneration, in Cerebrovascular Diseases, New York: Raven Press, 1989: 387-391.
186. Travis MA, Yonkers P, Hall E. Attenuation of posthemorrhagic and post-ischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Soc Neurosci Abstr 1987; 13: (abstract) 114.
187. Zuccarello M, Marsh JT, Schmitt G, Woodward J, Anderson DK. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 1980; 71: 98-104.
188. Steinke DE, Weir BK, Findlay JM, Tanabe T, Grace M, Krushelnycky BW. A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 1989; 24: 179-186.
189. Vollmer DG, Kassell NF, Hongo K, Ogawa H, Tsukahara T. Effect of nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm. Surg Neurol 1989; 31: 190-194.
190. Hall E. Beneficial effects of the 21-aminosteroid U74006F in acute central nervous system trauma and in hypovolemic shock. Acta Anaesthesiol Belg 1987; 38: 421-425.
191. Hall E, Yonkers P. Attenuation of post-ischemic cerebral hypoperfusion by the 21-aminosteroid U74006F. Stroke 1988; 19: 340-344.
192. Hall E, Parara K, Braughler M. 21-aminosteroid lopid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 1988; 19: 997-1002.
193. Natak JE, Schott RJ, Hall E, Braughler JM, D'Alecy LG. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs. Stroke 1988; 19: 1371-1378.
194. Perkins WJ, Milde N, Milde J, Michenfelder J. Effect of a 2-aminosteroid oxygen radical scavenger on neurological outcome following complete cerebral ischemia in dogs. J Neurosurg Anesthesiol 1989; 1: 118-119.
195. Sato PH, Hall E. Tirilazad mesylate protects vitamin C and E in brain ischemia-reperfusion injury. J Neurotrauma 1992; 58: 2263-2268.
196. Young W, Wojak JC, Decrescito V. 21-aminosteroid reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke 1988; 19: 1013-1019.
197. Hall E, Travis MA. The effects of the nonglucocorticoid 21-aminosteroid U74006F on acute cerebral hypoperfusion following experimental subarachnoid hemorrhage. Exp Neurol 1988; 102: 244-248.
198. Francel PC, Long BA, Malik JM, Tribble C, Jane JA, Kron IL. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage. J Neurosurg 1993; 79: 742-751.
199. Anderson DK, Hall E, Braughler JM, McCall J, Means E. Effect of delayed administration of U74006F (tirilazad mesylate) on recovery of locomotor function after experimental spinal cord injury. J Neurotrauma 1991; 8: 187-192.
200. Hall E. Effects of the 21-aminosteroid U74006F on post-traumatic spinal cord ischemia in cats. J Neurosurg 1988; 68: 462-465.
201. McIntosh TK, Thomas MJ, Smith DH, Banbury M. The novel 21-aminosteroid U74006F attenuates cerebral nd improves survival after brain injury in the rat. J Neurotrauma 1992; 9: 33-40.
202. Sanada T, Nakamura T, Nishimura MC, Isayama K, Pitts LH. Effect of U74006F on neurologic function and brain edema after fluid percussion injury in rats. J Neurotrauma 1993; 10(1): 65-71.
203. Hall ED, Yonkers PA, Andrus PK, Cox JW, Anderson DK. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma 1992; 9: S425-S442.
204. Varon S, Hagg T, Manthorpe M. Nerve growth factor in CNS repair and regeneration. Adv Exp Biol Med 1991; 296: 267-276.
205. Nieto-Sampedro M, Lewis ER, Cotman CW. Brain injury causes a time-dependent increase in neuronotrophic activity at the lesion site. Science 1982; 217: 860-861.
206. Needels DL, Nieto-Sampedro M, Whittemore SR, Cotman CW. Neuronotrophic activity for ciliary ganglion neurons. Induction following injury to the brain of neonatal, adult, and aged rats. Dev Brain Res 1985; 18: 275-284.
207. Whittemore SR, Nieto-Sampedro M, Needels DL, Cotman CW. Neuronotrophic factors for mammalian brain neurons: injury induction in neonatal, adult and aged rat brain. Dev Brain Res 1985; 20: 169-178.
208. Needels DL, Nieto-Sampedro M, Cotman CW. Induction of a neurite-promoting factor in rat brain following injury or deafferentation. Neurosci 1986; 18: 517-526.
209. Bakhit C, Armanini M, Bennett GL, Wong WLT, Hansen SE, Taylor R. Increase in glia-derived nerve growth factor following destruction of hippocampal neurons. Brain Res 1991; 560: 76-83.
210. NGFR mRNA by cells in the medial septum and diagonal band of Broca: correlations with cell survival, synaptic reorganization and sprouting. Mol Brain Res 1991; 11: 207-219.
211. Gomez-Pinilla FG, Lee JWK, Cotman CW. Basic FGF in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J Neurosci 1992; 12: 345-355.
212. Eckenstein FP, Shipley GD, Nishi R. Acidic and basic fibroblast growth factors in the nervous system: distribution and differential alteration of levels after injury of central versus peripheral nerve. J Neurosci 1991; 11: 412-419.
213. Logan A, Berry M. Transforming growth factor-β, and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 1993; 14: 337-343.
214. Logan A, Frautschy SA, Gonzalez AM, Baird A. A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors ollowing a localized cortical brain injury. J Neurosci 1992; 12: 3828-3837.
215. Kato T, Nakano S, Kogure K et al. The binding of basic fibroblast growth factor to ischaemic neurons in the rat. Neuropath Appl Neurobiol 1992; 18: 282-290.
216. Patterson SL, Grady SM, Bothwell M. Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res 1993; 605: 43-49.
217. Williams LR, Varon S, Peterson GM et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci 1986; 83: 9231-9235.
218. Kromer LF. Nerve growth factor treatment after brain injury prevents neuronal death. Science 1987; 235: 214-216.
219. Hagg T, Vahlsing HL, Manthorpe M, Varon S. Nerve growth factor infusion into the denervated adult rat hippocampal formation promotes its cholinergic reinnervation. J Neurosci 1990; 10: 3087-3092.
220. Shigeno T, Mima T, Takakura K et al. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J Neurosci 1991; 11: 2914-2919.
221. Tuszynski MH, Sang UH, Amaral DG, Gage FH. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 1990; 10: 3604-3614.
222. Koliatsos VE, Nauta HJW, Clatterbuck RE, Holtzman DM, Mobley WC, Price DL. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J Neurosci 1990; 10: 3801-3813.
223. Kawaja MD, Rosenberg MB, Yoshida K, Gage FH. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci 1992; 12: 2849-2864.
224. Anderson KJ, Dam D, Lee S, Cotman CW. Basic fibroblast factor prevents death of lesioned cholinergic neurons in vivo. Nature 1988; 332: 360-361.
225. Hofer MM, Barde Y-A. Brain-derived neurotrophic factor prevents neuronal death in vivo. Nature 1988; 331: 261-262.
226. Boniece IR, Wagner JA. Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis. J Neurosci 1993; 13: 4220-4228.
227. Nozaki K, Finklestein SP, Beal MF. Basic fibroblast growth factor protects against hypoxia-ischemia and NMDA neurotoxicity in neonatal rats. J Cereb Blood Flow Metab 1993; 13: 221-228.
228. Yamada K, Kinoshita A, Kohmura E et al. Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction. J Cereb Blood Flow Metab 1991; 11: 472-478.
229. Akaneya Y, Enokido Y, Takahashi M, Hantanaka H. In vitro model of hypoxia: basic fibroblast growth factor can rescue cultured CNS neurons from oxygen-deprived cell death. J Cereb Blood Flow Metab 1993; 13: 1029-1032.
230. Sinson G, Voddi M, McIntosh TK. Nerve growth factor administration attenuates cognitive but not behavioral motor dysfunction or hippocampal cell loss following fluid-percussion brain injury in rats. J Neurochem 1995; 65: 2209-2216.
231. Sinson G, Perri BR, Trojanowski JQ, Flamm ES, McIntosh TK. NGF attenuates cognitive deficits and neuronal loss after experimental brain injury. J Neurosci 1996. (In press.)
232. Sinson G, Voddi M, McIntosh TK. Combined fetal neural transplantation and nerve growth factor infusion: effects on neurological outcome following fluid-percussion brain injury in the rat. J Neurosurg 1996. (In press.)
233. Taft WC, Yang K, Dixon CE, Clifton GL, Hayes RL. Hypothermia attenuates the loss of hippocampal microtubule-associated protein 2 (MAP2) following traumatic brain injury. J Cereb Blood Flow Metab 1993; 13: 796-802.
234. Clifton GL, Jiang JY, Lyeth BG, Jenkins LW, Hamm RJ, Hayes RL. Marked protection by moderate hypothermia after experimental traumatic brain injury. J Cereb Blood Flow Metab 1991; 11: 114-121.
235. Lyeth BG, Jiang JY, Liu S. Behavioral protection by moderate hypothermia initiated after experimental traumatic brain injury. J Neutrotrauma 1993; 10: 57-64.
236. Dietrich DW, Alonso O, Mordecai RB, Globus YT, Ginsberg MD. Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol (Berlin) 1994; 87: 250-258.
237. Jiang JY, Lyeth BG, Kapasi MZ, Jenkins LW, Povlishock JT. Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat. Acta Neuropathol 1992; 84: 495-500.
238. Marion DW, Obrist WD, Carlier PM, Penrod LE, Darby JM. The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report, J Neurosurg 1993; 79: 354-362.
239. Clifton GL, Allen S, Barrodale et al. A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993; 10: 263-271.
240. Piek J, Chestnut RM, Marshall LF et al. Extracranial complications of severe head injury. J Neurosurg 1992; 77: 901-907.
241. Quattrocchi KB, Frank EH, Miller CH et al. Suppression of cellular immune activity following severe head injury. J Neurotrauma 1990; 7(2): 77-87.
242. Quattrocchi KB, Issel BW, Miller CH, Frank EH, Wagner airment of helper T-cell function following severe head injury. J Neurotrauma 1992; 9(1): 1-9.
243. Schoettle RJ, Kochanek PM, Magaree MJ, Uhl MW, Nemoto EM. Early polymorphonuclear leukocyte accumulation correlates with the development of post-traumatic cerebral edema in rats. J Neurotrauma 1990; 7: 207-217.
244. Biagas KV, Uhl MW, Schiding JK, Nemoto EM, Kochanek PM. Assessment of post-traumatic polymorphonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treatment. J Neurotrauma 1992; 9: 363-371.
245. Giulian D, Chen J, Ingeman JE, George JK, Noponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989; 9: 4416-4429,
246. Jorgensen MB, Wright DC, Diemer NH. Post-ischemic glucose metabolism is modified in the hippocampal CA, region depleted of excitatory input or pyramidal cells. J Cereb Blood Flow Metab 1990; 10: 243-251.
247. Morganti-Kossmann MC, Kossmann T, Wahl SM. Cytokines and neuropathology. Trends Pharmacol Sci 1992; 13: 286-291.
248. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. TINS 1995; 18: 130-136.
249. Feuerstein GZ, Liu T, Barone FC. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-α. Cerebrovasc Brain Metab Rev 1994; 6: 341-360.
250. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis factor in head injury. J Neuroimmunol 1990; 30: 213-217.
251. McClain C, Cohen D, Phillips R, Ott L, Young B. Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med 1991; 118: 225-231.
252. Ott L, McClain CJ, Gillespie M, Young B. Cytokines and metabolic dysfunction after severe head injury. J Neurotrauma 1994; 11: 447-472.
253. Woodroofe MN, Sarna GS, Wadhwa M et al. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmonol 1991; 33: 227-236.
254. Shohami E, Novikov M, Bass R, Yamin A, Gallily R. Closed head injury triggers early production of TNFα and IL-6by brain tissue. J Cereb Blood Flow Metab 1994; 14: 615-619.
255. Van HQ, Banos MA, Herregodts P, Hooghe R, Hooghe-Peters EL. Expression of interleukin (IL)-1β, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J Immunol 1992; 22: 2693-2971.
256. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985; 228: 497-499.
257. Taupin V, Toulmond S, Serrano A, Benavides J, Zavala F. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral type (p site) benzodiazepine ligand. J Neuroimmunol 1993; 42: 177-186.
258. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental brain injury induces expression of interleukin-1βmRNA in the rat brain. Mol Brain Res 1995; 30: 125-130.
259. Kaczorowski SL, Schiding JK, Kochanek PM. Effect of sCr-1 on brain polymorphonuclear leukocyte accumulation after brain injury in rats. 11th Annual Neurotrauma Symposium, 1993.
260. Toulmond S, Rothwell NJ. Interieukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 1995; 671: 261-266.